DE60029017D1 - Verwendung von blauen kupferproteinen - Google Patents

Verwendung von blauen kupferproteinen

Info

Publication number
DE60029017D1
DE60029017D1 DE60029017T DE60029017T DE60029017D1 DE 60029017 D1 DE60029017 D1 DE 60029017D1 DE 60029017 T DE60029017 T DE 60029017T DE 60029017 T DE60029017 T DE 60029017T DE 60029017 D1 DE60029017 D1 DE 60029017D1
Authority
DE
Germany
Prior art keywords
protein
apo
metal binding
cell
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029017T
Other languages
English (en)
Other versions
DE60029017T2 (de
Inventor
Inge Dierynck
Hubert Roelant
Wilfried Pauwels
Acker Lodewijk Van
Kerpel Octaaf De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Infectious Diseases Diagnostics BVBA
Original Assignee
Tibotec BVBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec BVBA filed Critical Tibotec BVBA
Application granted granted Critical
Publication of DE60029017D1 publication Critical patent/DE60029017D1/de
Publication of DE60029017T2 publication Critical patent/DE60029017T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
DE60029017T 1999-08-06 2000-08-04 Verwendung von blauen kupferproteinen Expired - Lifetime DE60029017T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14733999P 1999-08-06 1999-08-06
US147339P 1999-08-06
PCT/EP2000/007895 WO2001011358A2 (en) 1999-08-06 2000-08-04 Use of colored metal binding proteins

Publications (2)

Publication Number Publication Date
DE60029017D1 true DE60029017D1 (de) 2006-08-03
DE60029017T2 DE60029017T2 (de) 2007-06-28

Family

ID=22521174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029017T Expired - Lifetime DE60029017T2 (de) 1999-08-06 2000-08-04 Verwendung von blauen kupferproteinen

Country Status (7)

Country Link
EP (1) EP1282813B1 (de)
AT (1) ATE331218T1 (de)
AU (1) AU6838400A (de)
DE (1) DE60029017T2 (de)
ES (1) ES2267556T3 (de)
TW (1) TWI286601B (de)
WO (1) WO2001011358A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210019A (en) * 1990-03-30 1993-05-11 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Pseudomonas screening assay
ZA967411B (en) * 1995-09-01 1997-04-16 Novo Nordisk Biotech Inc Blue copper oxidase mutants with enhanced activity

Also Published As

Publication number Publication date
ES2267556T3 (es) 2007-03-16
DE60029017T2 (de) 2007-06-28
WO2001011358A2 (en) 2001-02-15
WO2001011358A3 (en) 2002-11-14
TWI286601B (en) 2007-09-11
EP1282813A2 (de) 2003-02-12
EP1282813B1 (de) 2006-06-21
AU6838400A (en) 2001-03-05
ATE331218T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
WO2004053079A3 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
ATE470150T1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
ATE256186T1 (de) Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten
TR199802385T2 (xx) TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler.
MY154826A (en) Fusion protein capable of binding vegf
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
WO2002063271A8 (en) Activity based probe analysis
ATE428928T1 (de) Verfahren zur einführung von heterologischen zellen in fische
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
DE69714775D1 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
DE60029017D1 (de) Verwendung von blauen kupferproteinen
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2001009611A3 (en) An vivo identification of specific binding molecules for cancer detection
WO2004050860A3 (en) Compositions, splice variants and methods relating to colon specific genes and proteins
WO2004013311A3 (en) Compositions and methods relating to ovarian specific genes and proteins
WO2003106648A3 (en) COMPOSITIONS AND METHODS RELATED TO BREAST SPECIFIC GENES AND PROTEINS
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins
WO2004052290A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2002088375A3 (en) Compositions and methods relating to breast specific genes and proteins
WO2004053077A3 (en) Compositions,splice variants and methods relating to breast specific genes and proteins
WO2004053081A3 (en) Compositions, splice variants and methods relating to prostate specific genes and proteins
SE0201392D0 (sv) Fusion polypeptide, use thereof and methods employing it
WO2003055982A3 (en) Compositions and methods relating to endometrial specific genes and proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition